ロード中...
New developments in the management of COPD: clinical utility of indacaterol 75 μg
Chronic obstructive pulmonary disease (COPD) is a global health challenge and a major cause of mortality worldwide. Bronchodilators, particularly long-acting β(2)-agonists and long-acting antimuscarinic agents, used singly or in combination, aim to improve lung function, reduce symptoms, prevent exa...
保存先:
| 主要な著者: | , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Dove Medical Press
2013
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3862584/ https://ncbi.nlm.nih.gov/pubmed/24353414 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/COPD.S24940 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|